Schiff Nutrition International, Inc. (NYSE:WNI), today announced results for the fiscal 2009 third quarter and nine months ended February 28, 2009.

Schiff Nutrition’s net sales were $49.9 million for the third quarter, compared to $46.2 million for the same period in fiscal 2008. For its fiscal 2009 third quarter, Schiff Nutrition reported net income of $3.6 million, or $0.13 per diluted share, as compared to $4.0 million, or $0.14 per diluted share, for the fiscal 2008 third quarter, which included a pre-tax compensation charge of approximately $630,000 related to the fiscal 2008 first quarter special dividend.

Schiff Nutrition’s net sales were $145.0 million for the nine months ended February 28, 2009, compared to $126.5 million for the same period in fiscal 2008. For the first nine months of fiscal 2009, Schiff Nutrition reported net income of $9.8 million, or $0.34 per diluted share, compared to $8.5 million, or $0.31 per diluted share, for the same period a year ago, which included a pre-tax compensation charge of approximately $4.3 million related to the fiscal 2008 first quarter special dividend.

Bruce Wood, President and Chief Executive Officer, stated, “We delivered a 7.9% increase in overall net sales in the third quarter, versus the year ago period. The increase was driven by substantial growth in our private label business and expanded distribution of our Schiff® MegaRed® new product, partially offset by a decline in our other branded business. Gross profit and operating income margins decreased in the quarter versus a year ago as a result of the change in sales mix and higher raw material costs. At the same time, we increased consumer marketing expenditures in the quarter, reflecting the commitment to supporting our brands, while reducing discretionary operating expenses.”

Wood added, “We continue to be encouraged with the performance of our Schiff MegaRed Omega-3 Krill Oil product. In February, we initiated a national marketing campaign to support its growth. Despite the extreme economic conditions generally, and the intense competitive climate in the supplements category, we have remained profitable and financially strong. We believe we have the resources to capitalize on MegaRed and other new growth opportunities and are well positioned to compete aggressively over the long term.”

Conference Call Information

Schiff Nutrition International will hold a conference call today, March 17 at 11:00 a.m. ET. The U.S. domestic access number is 800-291-5365. International participants should dial 617-614-3922. The participant passcode is 90486685. Please call in approximately ten minutes in advance. The conference call will be broadcast live over the Internet at http://www.schiffnutrition.com/press.asp, and the webcast will be available through April 6, 2009. A replay of the call will be available by dialing 888-286-8010 for domestic callers and 617-801-6888 for international callers; enter access code 99065683. The telephone replay will be available through March 19, 2009.

About Schiff Nutrition

Schiff Nutrition International, Inc. develops, manufactures, markets and distributes branded and private label vitamins, nutritional supplements and nutrition bars in the United States and throughout the world. To learn more about Schiff, please visit the web site www.schiffnutrition.com.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that are based on management’s beliefs and assumptions, current expectations, estimates, and projections. These statements are subject to known and unknown risks and uncertainties, certain of which are beyond the company’s ability to control or predict, and, therefore, actual results may differ materially. Any forward-looking statements are made pursuant to the Private Securities Litigation Reform Act of 1995 and, as such, speak only as of the date hereof. Schiff Nutrition disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise. You are cautioned not to place undue reliance on these forward-looking statements.

Important factors that may cause these forward-looking statements to be false include, but are not limited to: the level of customer and consumer acceptance of Move Free® Advanced, the level of customer and consumer acceptance of MegaRed, the inability to gain or maintain market distribution for MegaRed, the inability to successfully implement marketing and spending programs behind our Move Free, MegaRed and other branded products, the impact of raw material pricing, availability and quality (particularly relating to joint care products and ingredients from suppliers outside the United States, including China), the mix between branded and private label products, the inability to grow and/or maintain branded and private label sales, the inability to enforce or protect our intellectual property rights against infringement, the inability to achieve cost savings and operational efficiencies, the inability to increase operating margins and increase revenues, dependence on individual products, dependence on individual customers, the impact of competitive products and pricing (including private label), market and industry conditions (including pricing, demand for products and level of trade inventories), the impact of clinical studies regarding nutritional supplements, particularly relating to the joint care category, the success of product development, the inability to obtain customer acceptance of new product introductions, changes in laws and regulations, litigation and government or administrative regulatory action in the United States and internationally, including challenges to marketing, advertising or product claims, the inability to comply with or maintain new good manufacturing practices for the dietary supplement industry, the inability or increased cost to obtain product liability and general insurance, the uncertainty of market acceptance of new products, adverse publicity regarding nutritional supplements and/or their ingredients, the inability to find strategic transaction opportunities or the inability to successfully consummate or integrate a strategic transaction, changes in accounting standards, and other factors indicated from time to time in the company’s SEC reports, copies of which are available upon request from the company’s investor relations department or may be obtained at the SEC's web site (www.sec.gov). These risks and uncertainties should be carefully considered before making an investment decision with respect to shares of our common stock.

⁽¹⁾ In association with declaration of a special dividend, the three and nine months ended February 29, 2008, respectively, includes $630 and $4,290 compensation charge associated with dividend equivalents paid or payable on stock options and certain restricted stock units.

Schiff Nutrition International, Inc.
Joseph W. Baty, 801-975-5186
Chief Financial Officer
joeb@schiffnutrition.com
www.schiffnutrition.com
or
Lippert / Heilshorn & Associates
Keith Lippert, 212-838-3777
Kirsten Chapman, 415-433-3777
kchapman@lhai.com